Johnson & Johnson reports fiscal Q2 2026 results: revenue $25.31B, up 7% from a year earlier

Johnson & Johnson filed a Form 8-K with the SEC on Jul 15, 2026, 7:49 AM ET, reporting an event dated Jul 15, 2026. It covers Item 2.02 (Results of Operations and Financial Condition); Item 9.01 (Financial Statements and Exhibits). The results cover fiscal Q2 2026 (quarter ended Jun 28, 2026); figures below are from the company's XBRL financial data filed with the SEC.

• Revenue: $25.31B (+6.6% from $23.74B a year earlier)
• Net income: $5.53B (−0.1% from $5.54B a year earlier)
• Diluted EPS: $2.27 (−0.9% from $2.29 a year earlier)
• Form 8-K accepted by EDGAR Jul 15, 2026, 7:49 AM ET
• Accession number 0000200406-26-000146

SEC filing 8-K · accession 0000200406-26-000146 · sec.gov ↗